July 01, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Practices for ordering kidney biopsies or prescribing glucocorticoids for patients with immunoglobulin A nephropathy vary among physicians in Canada, according to study data published in Kidney360. Researchers wrote that understanding variability patterns for physicians treating patients with immunoglobulin A (IgA) nephropathy could help inform treatment strategies and improve adoption of updated
July 01, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

NEW ORLEANS — In this video from the National Kidney Foundation Spring Clinical Meetings, Paolo Cravedi, MD, PhD, discusses the…

NEW ORLEANS — In this video from the National Kidney Foundation Spring Clinical Meetings, Jared R. Hassler, MD, shares highlights…

NEW ORLEANS — In this video from the National Kidney Foundation Spring Clinical Meetings, Jared R. Hassler, MD, discusses how the…

NEW ORLEANS — In this video from the National Kidney Foundation Spring Clinical Meetings, Paolo Cravedi, MD, PhD, discusses the…

Second agent targeting BAFF and APRIL appears effective in phase III trial

In December 2021, the FDA approved the first therapy indicated to treat primary immunoglobulin A nephropathy. Since then, several…